John Shockley
Family Medicine · Lees Summit, MONPI 1639161003
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,220 and has fallen 98.5% since, to $18 in 2024.
Across 261 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$714
- AstraZeneca$308
- Novo Nordisk$302
- Pfizer$290
- Lilly USA, LLC$274
- Merck$240
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,816100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $714 |
| AstraZeneca | 16 | $308 |
| Novo Nordisk | 21 | $302 |
| Pfizer | 27 | $290 |
| Lilly USA, LLC | 18 | $274 |
| Merck | 16 | $240 |
| Boehringer Ingelheim | 15 | $238 |
| Amarin Pharma, Inc. | 9 | $165 |
| Johnson & Johnson | 12 | $153 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $100 |
| Abbott | 5 | $92 |
| Biohaven Pharmaceuticals, Inc. | 5 | $88 |
| Amgen | 6 | $86 |
| Kowa Pharmaceuticals America, Inc. | 6 | $74 |
| Novartis | 5 | $62 |
| GSK | 5 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Eisai Inc. | 3 | $44 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $33 |
| Shire North American Group Inc | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Genentech USA, Inc. | 2 | $24 |
| Antares Pharma, Inc. | 2 | $24 |
| Almatica Pharma LLC | 1 | $21 |
| Bayer | 1 | $16 |
| Bausch Health US, LLC | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Boston Scientific | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Vistapharm, Inc. | 1 | $11 |
How this compares
$3,816 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Lees Summit
- Veronica AnwuriLees Summit$31K
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.